Long-term implantation of a new implantable programmable insulin pump in two diabetic dogs

M. Scavini, P. W. Day, R. Philip

Research output: Contribution to journalArticlepeer-review


A positive-pressure implantable programmable pump with an integrated sideport and a detectable catheter was tested for long-term intraperitoneal insulin delivery in 2 diabetic dogs. Programming and refilling of the pump was simple and presented no problems during 28 months of pump function. During pump therapy an acceptable degree of glycemic control was maintained. No catheter occlusion occurred, and no skin erosions or infections were observed. Insulin in the pump reservoir was stable. After 9.5 months of pump function, flow progressively decreased because of insulin precipitation in the valved accumulator. Solubilization of these precipitates using 0.1 N NaOH injected in the reservoir and drained through the sideport normalized pump delivery rates. We conclude that this device is safe for long-term intraperitoneal insulin delivery. The sideport enables discrimination between different causes of pump malfunction and allows for the safe use of an alkaline solution to remove insulin precipitates, thus avoiding pump explantation.

Original languageEnglish
Pages (from-to)518-522
Number of pages5
JournalArtificial Organs
Issue number5
Publication statusPublished - 1992

ASJC Scopus subject areas

  • Biophysics


Dive into the research topics of 'Long-term implantation of a new implantable programmable insulin pump in two diabetic dogs'. Together they form a unique fingerprint.

Cite this